Shelby Group Enterprises, LLC. has announced the successful closure of a share purchase agreement with Perpetua Medical AB of Uppsala Sweden for the acquisition of Pharmacolog USA, Inc. This deal, which was finalized on December 6th, 2024, marks the first part of a two-part agreement between the two companies. Pharmacolog USA, Inc. manufactures and markets WasteLog™ for the analysis and verification of injectable controlled substance waste in Healthcare settings. WasteLog™ enhances existing Drug Diversion Prevention Programs by deterring and detecting potential diversion of dangerous controlled substances.
Read the full article: Shelby Group Enterprises LLC. Closes Share Purchase with Perpetua Medical, AB of Uppsala Sweden for Pharmacolog USA, Inc. //
Source: https://www.einpresswire.com/article/773016480/shelby-group-enterprises-llc-closes-share-purchase-with-perpetua-medical-ab-of-uppsala-sweden-for-pharmacolog-usa-inc